Key Takeaways
- INR1,000 crores milestone crossed, but Q4 was messy: Consolidated revenue hit the landmark for FY24, yet Q4 EBITDA collapsed to 6.1% from 15.9% YoY, driven by a INR50 crores domestic BTS revenue hole and INR11.3 crores in one-time charges across subsidiaries.
- The order book tells a better story: Order book rose to INR1,640 crores, anchored by a ~INR200 crores defense satellite payload win, and management sees visibility on more large-ticket BTS opportunities, though government timelines are unpredictable.
- Subsidiary cleanup is underway but incomplete: A cost reduction program in the French subsidiary triggered INR5 crores in severance costs, and another INR5 crores was provisioned for aged unbilled revenues. Management says these one-timers will not repeat and expects a profitability turnaround, but gave no quantified timeline.
- Standalone margins have room to run: Standalone EBITDA already sits at ~12.5%, with EMS contributing double-digit margins (not the 3-4% an analyst suggested). Management targets 13-15% standalone EBITDA, driven by BTS execution improvement and EMS operating leverage.
- What to watch next quarter: Whether the 800,000 euros variation order materializes, whether the French subsidiary actually turns profitable, and whether the large BTS opportunities management is chasing convert into firm orders after India's election season.
The Q4 Mess: What Went Wrong
- Domestic BTS lumpiness cratered EBITDA: A significant part of last year's Q4 domestic BTS revenue was booked in that quarter, while current Q4 domestic BTS revenues were lower by INR50 crores YoY. This single swing explains most of the consolidated EBITDA drop from 15.9% to 6.1%.
- One-time charges stacked up: Consolidated one-time charges totaled INR11.3 crores: INR5 crores severance from a French subsidiary overhead reduction program, INR5 crores provisioning for aged unbilled revenues on fixed-price contracts where variation orders did not fructify, and INR1.3 crores impairment on a standalone investment.
- The unbilled revenue provision is an auditor-driven policy shift: Customers with multi-year fixed-price contracts generate overruns, and the company keeps negotiating for variation orders. When the expected 800,000 euros order did not fructify in Q4, auditors advised a provisioning policy for aging unbilled revenues. Management does not expect further provisions in the coming year.
- Subsidiary other expenses were inflated by forex: Part of the increase in overseas subsidiaries' other expenses in rupee terms reflects Euro depreciation (INR83.7 last year vs INR89.9 this year), so the same Euro amount shows a higher rupee number.
Mallavarapu: "We also continue to work on our margin improvement plan for the subsidiary with a strong plan to reduce overhead costs, shift our business model away from the risky low-margin, fixed-price projects to higher-margin business, and improve the onshore-offshore mix."
Order Book & The BTS Pipeline
- Order book grew to INR1,640 crores: The headline addition was a ~INR200 crores defense satellite payload order won in Q4. BTS orders are executable over ~2.5 years, while EMS orders span 6-12 months, with supply chain easing moving engagement back to normal 6-8 month firm POs plus customer forecasts.
- More large BTS opportunities are visible but timing is uncertain: Management sees a couple of other significant opportunities of similar size (INR200 crores or more) and hopes to book at least some in the coming year, but Government of India timelines are unpredictable, especially with the election season.
- Three BTS focus areas: Space (strong for a long time, with visibility on significant opportunities), defense PSUs and DRDO for import substitution (land systems, indigenizing products from Russia), and electronic warfare and radar (working on various programs, some with foreign partners).
- Indigenization is a multi-pronged play: The company pursues proactive R&D for import substitution (seeing traction with first orders and RFQs), works with DRDO on tenders, and offers full systems to tri-services with technology collaboration.
- Order book growth was only 8% vs ~70% execution rate: When an analyst questioned whether this implies FY25 revenue growth should be tapered, management said not to relate order book growth to revenue growth because the horizon of firm POs varies, and reiterated the 18-20% medium-term target without directly addressing whether FY25 growth would be lower than FY24's 18%.
Mallavarapu: "We hope to book at least some of that in the coming year, but obviously, Government of India timelines tend to be unpredictable, and especially with the election season on now, we'll have to wait and see what happens after that."
Subsidiary Turnaround: The Plan
- The French subsidiary is being restructured: A cost reduction program triggered INR5 crores in severance costs in Q4, which management says will reduce manpower expenses going forward. The company declined to disclose how many employees were laid off.
- Business model is shifting away from fixed-price risk: The subsidiary is moving toward delivery center or time-and-material consulting-type business with shorter-cycle POs, away from the risky low-margin fixed-price projects that generated the aged unbilled revenue provision.
- Canada work is being shifted to India: A large part of the Canada technology work has been moved to India, where the company is executing Delhi Metro and Chennai Metro projects, including the design portion.
- Factoring arrangement eases receivables pressure: The company entered into a without-recourse factoring arrangement with BNP Bank for overseas subsidiaries' receivables, allowing them to factor and show as collection as soon as they invoice.
- Profitability fix takes priority over sales growth: Management expects overseas subsidiaries' sales growth may not exceed 8-10% in the coming year, but insists there will be a complete turnaround in profitability. Other expenses will not increase further and will be maintained at current levels at minimum.
- A mass production opportunity could drive incremental revenue: The subsidiary has an opportunity to design a product with a device company and hopes to enter mass production for it in the next year.
Desikan: "This year the focus is mainly on fixing the profitability, but nevertheless, there will be an increase, but it may not be more than 8% to 10%. That is for sure. But it will be a complete turnaround in terms of profitability that is definitely."
Margin Structure & Targets
- Margins are driven by business model, not segment: Built-to-spec business (design plus manufacture, with IP capture) should deliver ~20% margins. EMS (contract manufacturing, where the customer designs and the company builds to spec) carries lower margins but is still double-digit, not the 3-4% an analyst suggested.
- Standalone EBITDA is already at ~12.5%: Within that, EMS contributes 10.5-11% and built-to-spec contributes 14.5-15%. The lower share of built-to-spec in standalone this year was due to customer-related issues around certifying and assessing.
- Consolidated EBITDA target for FY25 is 12%: Management provided a range of 10-11% to 12%, with standalone EBITDA expected to improve to the 13-15% range. The improvement will come from BTS execution improvement and EMS operating leverage.
- Working capital improvement is structural but has a floor: Working capital reduced from 78 days to 61 days consolidated. Management confirmed the improvement is structural but expects it to settle around 65 days, not decline further.
- Debt will stay in a range, not keep falling: Consolidated debt reduced from INR263 crores to INR174 crores, with the debt-equity ratio improving from 1.25 to 0.85. However, debt is expected to remain in the INR170-180 crores range due to planned capex of INR25 crores, with finance costs between INR37-40 crores.
Desikan: "For the standalone EBITDA to improve up to 13% to 15% will be the range, I would say. So, that should be possible."
Growth Drivers & New Opportunities
- New customer pipeline spans three geographies and three segments: The company is pursuing new customers from Europe, North America, and the Middle East in defense, industrial, and electric mobility segments.
- Airbus is a small customer with room to grow: The company's share with Airbus is quite small, and it is working on a few opportunities to increase that.
- Metro and passenger train systems are a differentiated play: Management claims the company is the only one at a global level able to deliver these systems to train builders, and it is working on increasing the pipeline for domestic metro and passenger train projects, which could be a sizable opportunity.
- Revenue growth target is 18-20% over the medium term: Management reiterated this target and said order inflow will be in line with that growth rate.
Mallavarapu: "Our target to grow over medium term, definitely at 18% to 20% at a consolidated basis, continues to be something that we target to achieve."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Consolidated revenue growth | 18-20% growth rate | Medium term |
| Consolidated EBITDA margin | 12% (range: 10-11% to 12%) | FY25 |
| Standalone EBITDA margin | Improve to 13-15% range | FY25 |
| Working capital days | ~65 days | FY25 |
| Consolidated debt | INR170-180 crores range | FY25 |
| Finance cost | INR37-40 crores | FY25 |
| Capex | INR25 crores | FY25 |
| Variation order (Canada BTS) | Receive 800,000 euros | Current financial year (FY25) |
| Overseas subsidiaries profitability | Complete turnaround | FY25 |
| Overseas subsidiaries sales growth | Not more than 8-10% | FY25 |
| Further unbilled revenue provisions | None expected | FY25 |
| Large BTS order wins | Book at least some of the visible INR200 crores+ opportunities | Coming year, subject to government timelines post-elections |
Key Metrics
| Metric | Q4 FY24 |
|---|---|
| Consolidated revenue | ₹297 cr, flat QoQ, 6% lower YoY |
| Consolidated EBITDA | ₹18 cr (6.1%), vs ₹50 cr (15.9%) YoY |
| Standalone revenue | ₹169 cr, down 4% QoQ, 14% YoY |
| Standalone EBITDA | ₹17 cr (10.1%), vs ₹38 cr YoY |
| FY24 consolidated revenue | ₹1,091 cr, 18% higher YoY |
| FY24 consolidated EBITDA | ₹86 cr (7.9%), vs ₹76 cr (8.3%) for FY23 |
| FY24 standalone revenue | ₹632 cr, up 26% YoY |
| FY24 standalone EBITDA | ₹79 cr, up 47% from ₹54 cr |
| Order book | ₹1,640 cr, up 10% QoQ from ₹1,489 cr, up 8% YoY from ₹1,540 cr |
| Order inflow (FY24) | ~₹1,200 cr |
| Consolidated working capital days | 61 days, improved from 78 days |
| Consolidated debt | ₹174 cr, reduced from ₹263 cr |
| Debt-equity ratio | 0.85, improved from 1.25 |
| Standalone debt | ₹102 cr, reduced from ₹106 cr, includes ₹15 cr term loan taken during FY24 |
| One-time expenses (consolidated) | ₹11.3 cr: ₹5 cr severance costs (exceptional), ₹5 cr provision for aged unbilled revenues, ₹1.3 cr impairment of investment |
| Revenue mix: defence, space & aerospace | ~46% of overall revenue |
| Revenue mix: mobility | ~23% of overall revenue |
| Revenue mix: industrial & energy | ~26% of overall revenue |
| Revenue mix: healthcare | ~5% of overall revenue |
| Capex planned (FY25) | ₹25 cr |
| Interest cost (FY24) | ₹37 cr, expected ₹37-40 cr range for FY25 |
| Overseas subsidiaries Q4 revenue | ₹128 cr |
| Overseas subsidiaries employee cost | ₹67 cr |